The joint initiative stands to deliver a huge amount of data from the genome sequences of the 1001 Philippine TRVs. This will be made available to the public via the PH Rice GDB. From strengthening local expertise in crop genomics and bioinformatics, to providing more research opportunities—the program anticipates its potential in increasing and strengthening research output and capacity. The 1001 Rice Genome (1k1RG) Program is a promise to the future of rice in the Philippines as it ultimately aims to benefit farmers through accelerating the improvement and production of rice varieties.
Dr. Cynthia Saloma of PGC is a recipient of the Presidential Lingkod Bayan award
The PGC team’s dedication and resilience are a testament to the importance of scientific research and its ability to overcome even the most difficult of circumstances. #PGCParaSaBayan
Unlock the promise of genomics through HiFi sequencing
The DNA Sequencing Core Facility together with Noveaulab will be hosting a seminar on February 17, 2023, “PacBio Seminar: Unlock the promise of genomics through HiFi sequencing”
Date: Tuesday, February 17, 2023
Time: 1:00 PM Philippine Standard Time
Type: Onsite
Dr. Zuwei Qian, PacBio Director of Marketing for the APAC region will be the presenting the following topics:
HiFi reads: a new era for metagenome analysis
The long and short of it: PacBio sequencing for precision medicine
The Philippine Genome Center: Stockpiling for COVID-19
According to PGC Executive Director Cynthia Palmes-Saloma, the kit was made possible after genetic experts from others countries used Next Generation DNA Sequencing in trying to understand the nature of the COVID-19 virus. Among the facilities of the center is its DNA Sequencing Laboratory which was established in 2013.
Who is the Filipino, genomically speaking?
On human genetics, Dr. Maria Corazon De Ungria and Jazelyn Salvador briefly described their research on the genetics of Mangyans in Mindoro and of Philippine Negritos, respectively. They are both from the DNA Analysis Laboratory (DAL), Natural Sciences Research Institute, College of Science, UPD. Meanwhile, Prof. Jae Joseph Russell Rodriguez of the Institute of Biological Sciences, College of Arts and Sciences, UP Los Baños, also in collaboration with DAL, discussed his investigation into the human genetic history of the Sulu Archipelago.
Overcoming Challenges and Building Opportunities with Bioinformatics
The 2020 Bioinformatics Conference aims to bring together researchers, students, and professionals from the field of genomics and bioinformatics. Themed “#BioInfoPH: Overcoming Challenges, Building Opportunities”—the conference intends to surface the complexities of conducting bioinformatics and genomics research in the Philippines and therein address these challenges through the conference forum.
Philippine Genome Center
The Philippine Genome Center is a multidisciplinary research and service unit of the University of the Philippines for health, agriculture, biodiversity, and the environment.
Call for applications: 2019-2020 Bioinformatics Training and Internship Program (Batch 04: Jan-Feb)
Student applicants must be undergraduate or graduate students in good academic standing, enrolled in a science or engineering course at an accredited college or university in the Philippines. Young professional applicants must have a BS degree in a science or engineering field, and be a researcher and/or faculty member employed at a research or higher education institution in the Philippines.
1st National Genomics Conference Souvenir Program
Themed “Omics research in the next 5 years with the Philippine Genome Center”, the conference was organized to showcase the current and ongoing research programs of the Center. By engaging researchers, academics, decision-makers, and other stakeholders, PGC is bringing #PGCTalks to institutions keen on multi-omics research.
Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells
Renieramycin M (RM) is a KCN-stabilized tetrahydroisoquinoline purified from the blue sponge Xestospongia sp., with nanomolar IC50s against several cancer cell lines. Our goal is to evaluate its combination effects with doxorubicin (DOX) in estrogen receptor positive MCF-7 breast cancer cells.